Ciaftalan

Ciaftalan

SCHEMBL239995

[LiH].c1ccc2c(c1)-c1nc-2nc2[nH]c(nc3nc(nc4[nH]c(n1)c1ccccc41)-c1ccccc1-3)c1ccccc21

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
TDP1 Q9NUW8 4/20 0.45
RECQL P46063 2/20 0.45
THRB P10828 1/20 0.45
APEX1 P27695 1/20 0.45
BLM P54132 1/20 0.45
CA5A P35218 1/20 0.40
HSD17B10 Q99714 4/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C19 P33261 3/20 0.35
USP2 O75604 1/20 0.35
ALOX15 P16050 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
ALDH1A1 P00352 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPK1 P28482 3/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ciaftalan SCHEMBL590020 1.00 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL29018905 0.98 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL916755 0.98 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL5795179 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
SCHEMBL813083 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL29360952 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL29356273 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL15816 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL1728179 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL9314935 0.96 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122025741-A Sodium secondary battery, method for manufacturing same, and electric device 宁德时代新能源科技股份有限公司 2026-05-12 CN claimed
US-20260027385-A1 OXYGEN GUIDANCE OF HIGH DOSE RATE BRACHYTHERAPY WITH ELECTRON PARAMAGNETIC RESONANCE THE UNIVERSITY OF CHICAGO 2026-01-29 US claimed
US-20250180679-A1 COMPOSITE SPIN PROBES WITH SELECTABLE OXYGEN SENSITIVITY FOR ELECTRON PARAMAGNETIC RESONANCE O2M TECHNOLOGIES, LLC 2025-06-05 US claimed
US-20240341617-A1 IMPLANTABLE MICRO-COIL RESONATOR FOR DEEP TISSUE ELECTRON PARAMAGNETIC RESONANCE THE UNIVERSITY OF CHICAGO 2024-10-17 US claimed
CN-118308040-A Solar cell and insulating adhesive, battery assembly and photovoltaic system for solar cell 浙江爱旭太阳能科技有限公司 2024-07-09 CN claimed
CN-110010857-B Composite material based on metal phthalocyanine compound-carbon and application thereof in lithium-sulfur battery 天津大学 2022-07-05 CN claimed
CN-112117132-A Preparation method of molecular-grade metal phthalocyanine (phthalocyanine)/graphene (graphene oxide) composite material 天津工业大学 2020-12-22 CN claimed
CN-109390597-B High-load metal monatomic fuel cell catalytic material and preparation method thereof 北京海得利兹新技术有限公司 2020-10-30 CN claimed
CN-108752356-B A kind of graphene enhances green pesticide and its application of phthalocyanine photosensitizing effect 青岛大学 2019-11-08 CN claimed
CN-110010857-A Application based on metal phthalocyanine compound-carbon composite material and its in lithium-sulfur cell 天津大学 2019-07-12 CN claimed
EP-0775324-A2 METHOD FOR LABELING, VERIFICATION AND/OR IDENTIFYING AND DEVICE FOR IMPLEMENTING SAID METHOD MICRO TAG TEMED LTD (IL) 1997-05-28 EP claimed
WO-1996039933-A1 APPARATUS AND METHODOLOGY FOR DETERMINING OXYGEN IN BIOLOGICAL SYSTEMS TRUSTEES OF DARTMOUTH COLLEGE (US) 1996-12-19 WO claimed
US-5504429-A Probe for detecting and dosing molecular oxygen by means of electronic paramagnetic resonance spectrometry COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1996-04-02 US claimed
WO-1996005522-A2 METHOD FOR LABELING, VERIFICATION AND/OR IDENTIFYING AND DEVICE FOR IMPLEMENTING SAID METHOD MICRO TAG TEMED LTD. (IL) 1996-02-22 WO claimed
EP-0467747-B1 New crystals of radical lithium phthalocyanine, process for the preparation thereof and their use for \"in vivo\" determination of molecular oxygen COMMISSARIAT ENERGIE ATOMIQUE (FR) 1993-11-10 EP claimed
US-5258313-A Process for the detection or determination of oxygen by EPR spectrometry using radical lithium phthalocyanines and composition usable for in vivo determination COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1993-11-02 US claimed
EP-0352182-B1 OCTASUBSTITUTED LITHIUM PHTHALOCYANINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN EPR COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1993-05-05 EP claimed
US-5112597-A Electron spin resonance COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1992-05-12 US claimed
US-4996311-A Crystal structure, stability COMMISSARIAT A. L'ENERGIE ATOMIQUE (FR) 1991-02-26 US claimed
US-4987430-A Organic semiconductor device based on phthalocyanine CLARISSE CHRISTIAN (FR) 1991-01-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027385-A1 OXYGEN GUIDANCE OF HIGH DOSE RATE BRACHYTHERAPY WITH ELECTRON PARAMAGNETIC RESONANCE EPOR, TFRC, LPO MEN1 4298/4885KMT2A 1582/4885TDP1 4291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.